NAVEGA THERAPEUTICS, INC.

Search SAM.gov-registered contractors by mission sector, compliance posture and contract vehicle.

Mission sectors

Live demo

Arclight Demo Aerospace & Defense, Inc.

UEI DEMOPRIMEC01 · CAGE 0DEMO · Prime Corporate

CMMC Level 2 (C3PAO)
6 contract vehicles
Case studies & key people
Photo gallery & brand

See the finished profile Download it as an AI-ready Markdown file

A fictional company, built to show every section filled in.

Looking for something specific? Tour the demo profile

Open solicitations, teaming requests and recompetes, from SAM.gov and USAspending.

Pipeline

Popular vehicles

Try an example search

Real filters on live federal data. One click opens the results.

Looking for something specific? Tour the demo profile

AI capture analysis, capability statement grading and plain-language guides.

Analyze

Learn

Ask the AI Capture Analyst

Teaming analysis, best-fit partners, RFP fit and compliance matrices, grounded in TeamingIndex data.

Open the Intelligence Hub Grade a capability statementFree score in seconds. The PDF is never stored.

Looking for something specific? Tour the demo profile

Teaming agreements and proposals, plus how TeamingIndex verifies, protects and connects your data.

Product

Trust

Claim your company, free

Verify your UEI with your work email and control how primes see you. Every badge shows who vouches for it and when.

Claim your profile

Your workspace

Profile, compliance, team, saved searches and billing.

Go to your dashboard

Compare plans

Looking for something specific? Tour the demo profile

See TeamingIndex with real data before you sign up: a finished profile and working searches.

Sample pages

Example searches

Live demo

Arclight Demo Aerospace & Defense, Inc.

UEI DEMOPRIMEC01 · CAGE 0DEMO · Prime Corporate

CMMC Level 2 (C3PAO)
6 contract vehicles
Case studies & key people
Photo gallery & brand

See the finished profile Download it as an AI-ready Markdown file

A fictional company, built to show every section filled in.

Looking for something specific? Tour the demo profile

Popular

See it with data

NAVEGA THERAPEUTICS, INC. — UEI EDSAQ1DMYLK7 | TeamingIndex

Proven teaming graph

Learn more

Who NAVEGA THERAPEUTICS, INC. has actually worked with, from sub-awards that prime contractors report to the government. Use it to see which primes already trust this company.

No sub-award reports yet

Prime contractors report first-tier subcontracts of $30,000 or more. None name this company yet, which is common for companies that mostly win prime contracts or work below the reporting threshold.

See where agencies spend

Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.

SBIR/STTR portfolio

Learn more About SBIR/STTR

Small Business Innovation Research and Technology Transfer awards: early-stage federal R&D money this company has won.

SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects

Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.

Awards on record: 8 awards
Total awarded: $8,348,359
By phase: SBIR Phase I: 5
SBIR Phase II: 3

FedRAMP offerings

Learn more

Cloud services this company lists on the FedRAMP Marketplace, the government's record of cloud authorizations.

No FedRAMP Marketplace listing

No FedRAMP Marketplace listing is linked to this company. Cloud providers appear here automatically once FedRAMP lists their offering.

Find FedRAMP-authorized companies

Source: FedRAMP Marketplace · sync date not recorded

Exclusions & screening

Exclusions Screening list

Checks a prime runs before teaming: SAM.gov exclusions (debarment and suspension) and the government's Consolidated Screening List for export and sanctions lists.

SAM.gov exclusions

Not yet checked against SAM.gov exclusions.

Search exclusions on SAM.gov (opens in a new tab)

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

GSA CALC+ rate benchmark

Learn more

Hourly ceiling rates this company was awarded on GSA contracts, compared with the market for similar labor categories. Ceiling rates are the most an agency can be charged, not prices paid.

No GSA CALC+ rates on record

Companies with a GSA Multiple Award Schedule contract appear here after CALC+ publishes their awarded labor rates.

See GSA MAS holders

Source: GSA CALC+ awarded ceiling rates · sync date not recorded

Awards (most recent first)

Reformulating NT-Z001 and its delivery route to treat rheumatoid arthritis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $297,327
Sep 18, 2025 – Aug 31, 2026
Solicitation PAR24-131 (2024) · Topic NIAMS
Advancing precision pain medicines to the clinic
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $400,000
Sep 22, 2023 – Aug 31, 2025
Solicitation PAR23-069 (2023) · Topic NINDS
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $2,850,926
Sep 8, 2023 – May 31, 2025
Solicitation PAR17-457 (2017) · Topic NINDS
Optimization of a Gene Therapy for Chronic Pain in Human DRGs
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $275,377
Sep 22, 2021 – Aug 31, 2022
Solicitation NS20-011 (2020) · Topic 106
Treatment of Chemotherapy-Induced Peripheral Neuropathy via Genetic Repression of Sodium Channels
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $2,183,954
Sep 10, 2021 – Aug 31, 2023
Solicitation PA20-260 (2020) · Topic NCI
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,428,435
Jun 1, 2021 – May 31, 2023
Solicitation PAR17-457 (2017) · Topic 107
Treatment of Chemotherapy-Induced Peripheral Neuropathy via Genetic Repression of Sodium Channels
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $288,284
Sep 30, 2019 – Jul 31, 2020
Solicitation PA18-574 (2018) · Topic 102
Supplement to Promote Diversity and Inclusion, Female Scientist
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $624,056
Sep 30, 2019 – Aug 31, 2020
Solicitation PA18-837 (2018) · Topic NINDS

Compliance posture: unverified (SAM.gov baseline only)

About NAVEGA THERAPEUTICS, INC.

Identifiers

Ready to team with NAVEGA THERAPEUTICS, INC.?

Capabilities & differentiators

Compliance posture

Facility clearance

Past performance

Contract vehicles

Proven teaming graph

SBIR/STTR portfolio

FedRAMP offerings

Exclusions & screening

SAM.gov exclusions

GSA CALC+ rate benchmark

NAICS, PSC & socio-economic status

Teaming preferences

Business development contact

Corporate hierarchy

Data sources & provenance

Consolidated Screening List